Mutant huntingtin exon-1 impaired GTPCH and DHFR expression in plants and mice
Chiu‐Yueh HungiD, Chuanshu Zhu, Farooqahmed S. KitturiD, Maotao HeiD, Erland ArningiD, Jianhui ZhangiD, Asia J. Johnson, Gurpreet S. Jawa, Michelle D. ThomasiD, Tomas T. Ding, Jiahua XieiD
Abstract
Pathophysiology associated with Huntingtons disease (HD) has been studied extensively in various cell and animal models since the 1993 discovery of the mutant huntingtin (mHtt) with abnormally expanded polyglutamine (polyQ) tracts as the causative factor. However, the sequence of early pathophysiological events leading to HD still remains elusive. To gain new insights into the polyQ-induced early pathogenic events, we expressed Htt exon1 (Httex1) with a normal (21), or an extended (42 or 63) number of polyQ in tobacco plants, which lack an Htt ortholog to avoid any associated effects from endogenous Htt. Here, we show that transgenic plants accumulated Httex1 proteins with corresponding polyQ tracts, and that mHttex1 induced protein aggregation and affected plant growth, especially root and root hair development, in a polyQ length-dependent manner. Quantitative proteomic analysis of young roots from severely affected Httex1Q63 and unaffected Httex1Q21 plants showed that the most impaired protein by polyQ63 is a GTP cyclohydrolase I (GTPCH) along with many its related one-carbon (C1) metabolic pathway enzymes. GTPCH is a key enzyme involved in folate biosynthesis in plants and tetrahydrobiopterin (BH4) biosynthesis in mammals. Validating studies in 4-week-old R6/2 HD mice expressing a mHttex1 showed reduced levels of GTPCH and dihydrofolate reductase (DHFR, a key folate utilization/alternate BH4 biosynthesis enzyme), and impaired C1 and BH4 metabolisms. Our findings from mHttex1 plants and mice reveal impaired expressions of GTPCH and DHFR and contribute to a better understanding of mHtt-altered C1 metabolism and C1 interconnected BH4 metabolism leading to the pathogenesis of HD.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Developmental and physiological impacts of pathogenic human huntingtin protein in the nervous system
Tadros A. Hana, Veronika G. Mousa, … Kiel G. Ormerod·Neurobiology of DiseasePeer-reviewed·Nov 12, 2024
- Mutant Huntingtin impairs neurodevelopment in human brain organoids through CHCHD2-mediated neurometabolic failure
Paweł Lisowski, Selene Lickfett, … Alessandro Prigione·Nature CommunicationsPeer-reviewed·Aug 22, 2024
- Design and characterisation of mutant and wild-type huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems
R. J. Harding, P. Loppnau, … C. Arrowsmith·bioRxiv·Feb 5, 2019
- Structure-function dissection of huntingtin exon 1 identifies a PRD-driven modifier of neuronal toxicity in Huntington's disease
Raffaele Iennaco, Camilla Maffezzini, … Elena F. Cattaneo·bioRxiv·Jul 27, 2026
- Rescue of aberrant huntingtin palmitoylation ameliorates mutant huntingtin-induced toxicity
Fanny L. Lemarié, Nicholas S. Caron, … Michael R. Hayden·Neurobiology of DiseasePeer-reviewed·Aug 11, 2021
- A role of cellular translation regulation associated with toxic Huntingtin protein
H. Joag, V. Ghatpande, … A. Majumdar·bioRxiv·Jul 1, 2019